Enhanced FSTL3 bolstered RCC cell proliferation, while FSTL3 knockdown attenuated the proliferation (in contrast with CMNC or CMsi-NC, Figure 4B, 4C). The gene discussed is FSTL3; the disease is renal cell carcinoma.